Nimustine
- Generic Name
- Nimustine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H13ClN6O2
- CAS Number
- 42471-28-3
- Unique Ingredient Identifier
- 0S726V972K
- Background
Nimustine has been used in trials studying the treatment of Glioblastoma.
- Indication
适用于脑瘤、肺癌、慢性白血病、恶性淋巴瘤、消化道癌。
- Associated Conditions
- -
- Associated Therapies
- -
US FDA Doesn't Budge On 'ACNU' Switch Requirements Questioned By OTC Industry
The US FDA maintained its stance on 'ACNU' switch requirements, despite OTC industry concerns. The proposal to make more formulations available nonprescription through 'novel switches' evolved from a 2012 idea to a final rule in December 2022.
Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA finalizes a rule for nonprescription drugs with an Additional Condition for Nonprescription Use (ACNU), allowing marketing without a prescription if an additional condition ensures safe and effective consumer use. This aims to expand safe, effective nonprescription drug options and improve public health by increasing consumer access.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath